Exalt Clinical Research /ID# 283814 — Chula Vista, California

Exalt Clinical Research /ID# 283814 is a clinical research site located in Chula Vista, California, United States 91910.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Exalt Clinical Research /ID# 283814 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Alopecia Areata.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chula Vista

Browse all research sites in California · View every site in Chula Vista

• Scripps Mercy Hospital Chula Vista
• Scripps Mercy Hospital
• Sharp Memorial Hospital
• Scripps Hospital
• University of California, San Diego - Chula Vista
• Profil Institute for Clinical Research
• Research Site
• Prosciento
• GSK Investigational Site
• GW Research
• eStudySite
• Velocity Clinical Research-Chula Vista

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Exalt Clinical Research /ID# 283814?

Exalt Clinical Research /ID# 283814 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Exalt Clinical Research /ID# 283814 conducted?

Exalt Clinical Research /ID# 283814 has 1 clinical trials on record, with 1 currently active. Their work covers Alopecia Areata.

Is Exalt Clinical Research /ID# 283814 accredited by Crixeo Clinical Trials?

Exalt Clinical Research /ID# 283814 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Exalt Clinical Research /ID# 283814?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.